Systematic (IUPAC) name | |
---|---|
(3S)-5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
|
|
Identifiers | |
CAS Registry Number | 58662-84-3 |
ATC code | None |
PubChem | CID: 3033985 |
ChemSpider | 2298544 |
UNII | RN43209SMA |
ChEMBL | CHEMBL351821 |
Chemical data | |
Formula | C16H12ClN3O3 |
Molecular mass | 329.74 |
|
|
|
|
(what is this?) (verify) |
Meclonazepam[1] ((S)-3-methylclonazepam) was discovered by a team at Hoffmann-La Roche in the 1970s and is a drug which is a benzodiazepine derivative similar in structure to clonazepam.[2] It has sedative and anxiolytic actions like those of other benzodiazepines,[3] and also has anti-parasitic effects against the parasitic worm Schistosoma mansoni.[4]
See also
References
- ^ U.S. Patent 4,031,078
- ^ The Lundbeck Institute. "Meclonazepam". Psychotropics. Lundbeck.
- ^ Ansseau, M.; Doumont, A.; Thiry, D.; Von Frenckell, R.; Collard, J. (1985). "Initial study of methylclonazepam in generalized anxiety disorder. Evidence for greater power in the cross-over design". Psychopharmacology 87 (2): 130–135. doi:10.1007/bf00431795. PMID 3931136.
- ^ O'Boyle, C.; Lambe, R.; Darragh, A. (1985). "Central Effects in Man of the Novel Schistosomicidal Benzodiazepine Meclonazepam". European Journal of Clinical Pharmacology 29 (1): 105–108. doi:10.1007/bf00547377. PMID 4054198.
Further reading
- Abdul-Ghani, R. A.; Loutfy, N.; Hassan, A. (2009). "Experimentally promising antischistosomal drugs: A review of some drug candidates not reaching the clinical use". Parasitology Research 105 (4): 899–906. doi:10.1007/s00436-009-1546-2. PMID 19588166.
|